GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (WBO:MARI) » Definitions » Net Policyholder Benefits/Claims

Marinomed Biotech AG (WBO:MARI) Net Policyholder Benefits/Claims


View and export this data going back to 2018. Start your Free Trial

What is Marinomed Biotech AG Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


Marinomed Biotech AG (WBO:MARI) Business Description

Industry
Traded in Other Exchanges
Address
Hovengasse 25, Korneuburg, AUT, 2100
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.